Aas-S200 Cadmium Nephrotoxicity Test Urine & Blood for Kidney Patients

Name: Aas-S200 Cadmium Nephrotoxicity Test Urine & Blood for Kidney Patients
Brand: Beijing Bohui Innovation Biotechnology Group Co., Ltd
SKU: 2153914992

Beijing, ChinaBeijing Bohui Innovation Biotechnology Group Co., Ltd

US$10,500.00-13,500.00

1 Piece

Product profile

Customization

Available

Classification

Physiological Functions of Diagnosis and Monitoring Equipment

Type

Trace Element Analyzer

Model NO.

AAS-S200

Certification

CE, ISO13485, Nmpa

Group

Full Range

Weight

45kg

Detection Limit

Pb≤4 Pg

Detection Deviation

≤10%

Real-Time Detection Time

1.5 Mins/Test

Communication Interface

USB;HDMI;Ethernet Interface

Test Repeatability

≤10%

Correlation Coefficient

R≥0.995

Power Supply

Voltage:220V;Frequency:50Hz;Current Rating:0A;

Running Time

Continuously Once Powered on

Operating Temperature Range

(10-30)℃

Operating Humidity Range

≤70%

Specification

782 mm×560mm×338 mm

Origin

China. Beijing

HS Code

9027300000

Key features

Dual Element Detection: Simultaneously measures lead and cadmium levels in blood, urine, and breast milk.

Rapid Analysis Time: Completes a single sample test in just 1.5 minutes for high efficiency.

Advanced Technology: Uses atomic absorption spectrometry with self-absorption background correction.

Multiple Sample Support: Compatible with whole blood, serum, urine, and breast milk specimens.

Automated Operation: Supports connection to an automatic autosampler for streamlined workflow.

Comprehensive Certifications: Holds CE, ISO13485, and Nmpa certifications for medical safety and compliance.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceExperienced TeamSelf-branded

Beijing Bohui Innovation Biotechnology Group Co., Ltd

Beijing, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 1 year CertifiedNearest Port: Tianjin PortAverage Response Time: ≤2.89h

AI-Powered supplier vetting

SummaryBeijing Bohui Innovation Biotechnology Group Co., Ltd., founded in 2001, is a high-tech biomedical enterprise engaged in R&D, production, sales, and after-sales service. The company is headquartered in Beijing and listed on the Shenzhen Stock Exchange. It has ISO and CE certifications, ensuring quality assurance. The company demonstrates a clear procedure for handling corrective actions and customer complaints. It offers full customization services but lacks overseas warehouses and showrooms. Financial data from the last year is incomplete, making financial credibility uncertain. The company participates in trade shows and has a proximity advantage to Tianjin Port.

Supplier typeThe supplier is a combined type company named Beijing Bohui Innovation Biotechnology Group Co., Ltd., specializing in technical development and sales of medical devices and instruments.

CertificationsThe company holds ISO9001:2015, ISO45001:2018, ISO14001, and CE certifications, indicating compliance with quality and environmental standards.

After-Sales capabilityThe supplier has a clear procedure and followed records for corrective and preventive actions, as well as handling customer complaints.

R&D capabilityThe company has demonstrated innovation capability with new products developed in the past year.

Customization capabilityThe supplier offers a range of customization services, including full customization, indicating strong customization capability.